College of Pharmacy, Dalhousie University, Halifax, NS, Canada.
Department of Pharmacy, Nova Scotia Health, Halifax, NS, Canada.
Ann Pharmacother. 2023 Jul;57(7):855-866. doi: 10.1177/10600280221134539. Epub 2022 Nov 11.
To determine whether implementation of antimicrobial stewardship (AMS) interventions improve management of bacteriuria in hospitalized adults.
EMBASE, MEDLINE, CINAHL, and Clinical Trials Registries via Cochrane CENTRAL were searched from inception through May 2021. Reference lists of included studies were searched, and Scopus was used to retrieve articles that cited included references.
Randomized and nonrandomized trials, controlled before-after studies, interrupted time-series studies, and repeated measures studies evaluating AMS interventions for hospitalized adult inpatients with bacteriuria were included. Risk of bias was assessed independently by 3 team members and compared. Results were summarized descriptively.
The search yielded 5509 articles, of which 13 met inclusion criteria. Most common interventions included education (N = 8) and audit and feedback (N = 5) alone or in combination with other interventions. Where assessed, resource and antimicrobial use primarily decreased and appropriateness of antimicrobial use improved; however, impact on guideline adherence was variable. All studies were rated as having unclear or serious risk of bias. This review summarizes and assesses the quality of evidence for AMS interventions to improve the management of bacteriuria. Results provide guidance to both AMS teams and researchers aiming to develop and/or evaluate AMS interventions for management of bacteriuria.
This review demonstrated benefit of AMS interventions on management of bacteriuria. However, most studies had some risk of bias, and an overall effect across studies is unclear due to heterogeneity in outcome measures.
确定抗菌药物管理(AMS)干预措施的实施是否能改善住院成人菌尿症的管理。
通过 Cochrane 中心的 EMBASE、MEDLINE、CINAHL 和临床试验登记处,从建库起至 2021 年 5 月进行检索。检索纳入研究的参考文献,并使用 Scopus 检索引用纳入文献的文章。
纳入了评估抗菌药物管理干预措施对住院成年菌尿症患者的随机和非随机试验、对照前后研究、中断时间序列研究和重复测量研究。由 3 名团队成员独立评估偏倚风险并进行比较。结果以描述性方式进行总结。
检索结果产生了 5509 篇文章,其中 13 篇符合纳入标准。最常见的干预措施包括教育(N=8)和审核与反馈(N=5)单独或与其他干预措施联合使用。在评估的研究中,资源和抗菌药物的使用主要减少,抗菌药物使用的适当性提高;然而,对指南遵循的影响是可变的。所有研究均被评为存在不明确或严重的偏倚风险。本综述总结和评估了改善菌尿症管理的抗菌药物管理干预措施的证据质量。结果为旨在开发和/或评估抗菌药物管理干预措施以管理菌尿症的抗菌药物管理团队和研究人员提供了指导。
本综述表明,抗菌药物管理干预措施对菌尿症的管理有益。然而,由于研究结果之间存在异质性,大多数研究存在一定的偏倚风险,且整体效果仍不明确。